Biogen's new Alzheimer's drug comes with "serious cost concerns" for millions on Medicare
At $56,000 per year, Aduhelm "could be a real budget-buster" for the government health program, some experts say.
Full Article
Biogen's new Alzheimer's drug comes with "serious cost concerns" for millions on Medicare
Upworthy
0 shares
1 views
You might like
Related news coverage
Supreme Court Dismisses Challenge To Affordable Care Act
Newsy
Watch Video The Supreme Court's latest rejection of a Republican effort to dismantle “Obamacare” signals anew that the GOP..
-
What universal healthcare should look like
Mashable
-
New Drug Could Cost the Government as Much as It Spends on NASA
NYTimes.com
-
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
Advertisement
More coverage
FDA Approves Highly Debated Alzheimer’s Drug
Newsy
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..